Multiple Sclerosis Clinical Trials in Houston

Showing 341-360 of 517 trials

Imatinib Mesylate in Treating Patients With Metastatic Melanoma

NCT00027586

RATIONALE: Imatinib mesylate may interfere with the growth of tumor cells and may be an effective treatment for metastatic melanoma. PURPOSE: Phase II trial to study the effectiveness of imatinib mesylate in treating patients who have metastatic melanoma.

MelanomaSkin Neoplasms

M.D. Anderson Cancer Center22 participantsStarted Sep 2001

Houston, Texas, United States

COMPLETEDPhase 1< 1 mile

Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis

NCT01585766

The purpose of this study is to evaluate the safety and tolerability of ascending intravenous (IV) and subcutaneous (SC) doses of MEDI-551 in adult subjects with relapsing forms of multiple sclerosis (MS).

Multiple Sclerosis, Relapsing Forms

MedImmune LLC56 participantsStarted Apr 2012

Scottsdale, Arizona, United States • Long Beach, California, United States • Sacramento, California, United States +13 more locations

Imatinib Mesylate in Treating Patients With Metastatic Melanoma

Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis

Multiple Sclerosis Trials in Other Cities

Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies

Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

CoSeal for Hemostasis of Aortic Anastamoses

A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer

Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis

TR(ACE) Assay Clinical Specimen Study

Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer

Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancer

A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer

Resilience Against Depression Disparities (Also Known as Resilience Education to Reduce Depression Disparities)

A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

TARGET Intracranial Aneurysm Coiling Registry

Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis

A Study of The Impact of Severe Hepatic Impairment on the Pharmacokinetics and Safety of Vemurafenib in BRAF V600 Mutation-Positive Cancer Participants

Other Conditions in Houston